Cheyenne Quach
Medical · Mountain View, CANPI 1184350597
Payments from drug & device makers
Across 116 payments — averaging $23.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$390
- Lilly USA, LLC$330
- Bayer$287
- Novo Nordisk$238
- Amgen$207
- Mannkind Corporation$184
- plus $1K from 19 others
What the payments were for
- Food & beverage$2,69299%
- Education$291%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 16 | $390 |
| Lilly USA, LLC | 14 | $330 |
| Bayer | 13 | $287 |
| Novo Nordisk | 12 | $238 |
| Amgen | 9 | $207 |
| Mannkind Corporation | 7 | $184 |
| Regeneron Healthcare Solutions, Inc. | 4 | $138 |
| Abbott | 6 | $128 |
| AstraZeneca(2 entities) | 5 | $117 |
| Xeris Pharmaceuticals, Inc. | 4 | $91 |
| Boehringer Ingelheim | 4 | $76 |
| Radius Health, Inc. | 4 | $76 |
| Corcept Therapeutics | 3 | $70 |
| Dexcom, Inc. | 2 | $68 |
| Organon | 2 | $59 |
| Sanofi | 2 | $43 |
| AbbVie | 1 | $34 |
| Averitas Pharma Inc. | 1 | $31 |
| Amryt Pharma Holdings Ltd | 1 | $29 |
| Kyowa Kirin, Inc. | 1 | $28 |
| Sanofi-aventis U.S. LLC | 1 | $28 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
| Exact Sciences | 1 | $18 |
| Halozyme Inc | 1 | $13 |
| Antares Pharma, Inc. | 1 | $13 |
How this compares
$2,721 in reported general payments places this provider in the 75th percentile of 2,087 medical providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 161 | $278,184 |
| JardianceEmpagliflozin | 147 | $198,649 |
| TrulicityDulaglutide | 79 | $136,545 |
| FarxigaDapagliflozin Propanediol | 86 | $106,339 |
| MounjaroTirzepatide | 68 | $104,232 |
| ForteoTeriparatide | 17 | $82,914 |
| TymlosAbaloparatide | 30 | $78,766 |
| Teriparatide | 28 | $75,809 |
| GenvoyaElviteg/Cob/Emtri/Tenof Alafen | 16 | $63,695 |
| JanuviaSitagliptin Phosphate | 55 | $47,753 |
| AfrezzaInsulin Regular, Human | 13 | $41,979 |
| Tresiba Flextouch U-200Insulin Degludec | 23 | $38,103 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 21 | $37,088 |
| RybelsusSemaglutide | 18 | $29,148 |
| Repatha SureclickEvolocumab | 34 | $27,901 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro, Forteo | $330 | $323,692164 claims |
| Novo NordiskOzempic, Rybelsus, Novolog | $238 | $310,974193 claims |
| Boehringer IngelheimJardiance, Tradjenta, Synjardy Xr | $76 | $228,667176 claims |
| AstraZenecaFarxiga, Symbicort | $117 | $109,65698 claims |
| Radius Health, Inc.Tymlos | $76 | $78,76630 claims |
| Mannkind CorporationAfrezza | $184 | $41,97913 claims |
| GSKTrelegy Ellipta | $390 | $23,25227 claims |
| BayerKerendia | $287 | $20,18411 claims |
| AbbVieSynthroid | $34 | $7,94191 claims |
| Sanofi-aventis U.S. LLCLantus | $28 | $5,23923 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,087 medical providers in California.
Other medical in Mountain View
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- David DoriguzziLancaster$514K
- Alison GracomIrvine$467K
- Jeffrey BonnaudLos Angeles$314K
- Ana TorresLaguna Beach$229K
- Heather ParlettRedlands$168K
- Deirdre MoxleyFullerton$149K
- Tri leGardena$127K
- Linda RankLadera Ranch$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.